Clinical features and molecular mechanism of muscle wasting in end stage renal disease

키워드

참고문헌 (116)

1. Rossing P, "KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease", Kidney Int, 102, pp.S1~S127 (2022)
2. Kovesdy CP, "Epidemiology of chronic kidney disease:an update 2022", Kidney Int Suppl, 12, pp.7~11 (2022)
3. Hashmi MF, "Endstage renal disease" (2022), StatPearls
4. Hill NR, "Global prevalence of chronic kidney disease-a systematic review and meta-analysis", PloS one, 11, pp.e0158765~ (2016)
5. Bello AK, "Epidemiology of peritoneal dialysis outcomes", Nat Rev Nephrol, 18, pp.779~793 (2022)
6. 홍유아, "Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS)", Kidney Research and Clinical Practice, 40(1), pp.52~61 (2021), 대한신장학회[DOI]
7. Shu X, "Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients : a systematic review and meta-analysis", J Cachexia Sarcopenia Muscle, 13, pp.145~158 (2022)
8. Volpi E, "Muscle tissue changes with aging", Curr Opin Clin Nutr Metab Care, 7, pp.405~ (2004)
9. Mitchell WK, "Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review", Front Physiol, 3, pp.260~ (2012)
10. Wilkinson DJ, "The age-related loss of skeletal muscle mass and function : measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans", Ageing Res Rev, 47, pp.123~132 (2018)
11. Kitamura M, "The impact of muscle mass loss and deteriorating physical function on prognosis in patients receiving hemodialysis", Sci Rep, 11, pp.22290~ (2021)
12. Cheng TC, "Muscle wasting in chronic kidney disease : mechanism and clinical implications-a narrative review", Int J Mol Sci, 23, pp.6047~ (2022)
13. Wang XH, "Mechanisms of muscle wasting in chronic kidney disease", Nat Rev Nephrol, 10, pp.504~516 (2014)
14. Balafa O, "Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients", Clin J Am Soc Nephrol, 6, pp.561~566 (2011)
15. Wathanavasin W, "Prevalence of sarcopenia and its impact on cardiovascular events and mortality among dialysis patients : a systematic review and meta-analysis", Nutrients, 14, pp.4077~ (2022)
16. Yang L, "Physical function and all-cause mortality in patients with chronic kidney disease and end-stage renal disease : a systematic review and meta-analysis", Int Urol Nephrol, 55, pp.1219~1228 (2023)
17. Rosenberg I, "Epidemiologic and methodologic problems in determining nutritional status of older persons(Summary comments)", Am J Cli Nutr, 50, pp.1231~1233 (1989)
18. Cruz-Jentoft AJ, "Sarcopenia : European consensus on definition and diagnosis : report of the European working group on sarcopenia in older people", Age Ageing, 39, pp.412~423 (2010)
19. Cruz-Jentoft AJ, "Sarcopenia", Lancet, 393, pp.2636~2646 (2019)
20. 백지연, "Korean Working Group on Sarcopenia Guideline: Expert Consensus on Sarcopenia Screening and Diagnosis by the Korean Society of Sarcopenia, the Korean Society for Bone and Mineral Research, and the Korean Geriatrics Society", Annals of geriatric medicine and research, 27(1), pp.9~21 (2023), 대한노인병학회[DOI]
21. Sabatino A, "Estimation of muscle mass in the integrated assessment of patients on hemodialysis", Front Nutr, 8, pp.697523~ (2021)
22. Chamney PW, "A whole-body model to distinguish excess fluid from the hydration of major body tissues", Am J Clin Nutr, 85, pp.80~89 (2007)
23. Ikizler TA, "KDOQI clinical practice guideline for nutrition in CKD : 2020 update", Am J Kidney Dis, 76, pp.S1~S107 (2020)
24. Kittiskulnam P, "Sarcopenia among patients receiving hemodialysis : weighing the evidence", J Cachexia Sarcopenia Muscle, 8, pp.57~68 (2017)
25. Sánchez-Tocino ML, "Sarcopenia and mortality in older hemodialysis patients", Nutrients, 14, pp.2354~ (2022)
26. Seto Y, "Long-term body composition changes in patients undergoing hemodialysis : a single-center retrospective study", Ren Replace Ther, 8, pp.1~8 (2022)
27. Pellicano R, "Longitudinal body composition changes due to dialysis", Clin J Am Soc Nephrol, 6, pp.1668~1675 (2011)
28. John SG, "Natural history of skeletal muscle mass changes in chronic kidney disease stage 4 and 5 patients : an observational study", PloS one, 8, pp.e65372~ (2013)
29. Silva Maryanne Zilli Canedo, "Age, diabetes mellitus, and dialysis modality are associated with risk of poor muscle strength and physical function in hemodialysis and peritoneal dialysis patients", Kidney Research and Clinical Practice, 40(2), pp.294~303 (2021), 대한신장학회[DOI]
30. Birajdar N, "Hand grip strength in patients on maintenance hemodialysis : an observational cohort study from India", Indian J Nephrol, 29, pp.393~ (2019)
31. Van Loon I, "A closer look at the trajectory of physical functioning in chronic hemodialysis", Age Ageing, 46, pp.594~599 (2017)
32. Kurella Tamura M, "Functional status of elderly adults before and after initiation of dialysis", N Engl J Med, 361, pp.1539~1547 (2009)
33. Delmonico MJ, "Longitudinal study of muscle strength, quality, and adipose tissue infiltration", Am J Clin Nutr, 90, pp.1579~1585 (2009)
34. Goodpaster BH, "The loss of skeletal muscle strength, mass, and quality in older adults : the health, aging and body composition study", J Gerontol A Biol Sci Med Sci, 61, pp.1059~1064 (2006)
35. Chen X, "Physical performance and muscle strength rather than muscle mass are predictor of all-cause mortality in hemodialysis patients", Front Public Health, 11, pp.1087248~ (2023)
36. Wang XH, "Pathophysiological mechanisms leading to muscle loss in chronic kidney disease", Nat Rev Nephrol, 18, pp.138~152 (2022)
37. Mitch WE, "Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway", N Engl J Med, 335, pp.1897~1905 (1996)
38. Gomes MD, "Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy", Proc Natl Acad Sci U S A, 98, pp.14440~14445 (2001)
39. Bodine SC, "Identification of ubiquitin ligases required for skeletal muscle atrophy", Science, 294, pp.1704~1708 (2001)
40. Du J, "Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions", J Clin Invest, 113, pp.115~123 (2004)
41. Wang K, "Chronic kidney disease-induced muscle atrophy : molecular mechanisms and promising therapies", Biochem Pharmacol, 208, pp.115407~ (2022)
42. Spoto B, "Insulin resistance in chronic kidney disease : a systematic review", Am J Physiol Renal Physiol, 311, pp.F1087~ (2016)
43. Zhang L, "Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy", J Am Soc Nephrol, 21, pp.419~427 (2010)
44. Ding H, "Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect", J Clin Invest, 97, pp.1064~1075 (1996)
45. Carrero JJ, "Etiology of the protein-energy wasting syndrome in chronic kidney disease : a consensus statement from the International Society of Renal Nutrition and Metabolism(ISRNM)", J Ren Nutr, 23, pp.77~90 (2013)
46. Ábrigo J, "Role of oxidative stress as key regulator of muscle wasting during cachexia", Oxid Med Cell Longev, 2018, pp.2063179~ (2018)
47. Hyatt H, "Mitochondrial dysfunction induces muscle atrophy during prolonged inactivity : a review of the causes and effects", Arch Biochem Biophys, 662, pp.49~60 (2019)
48. Mitch WE, "Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes", J Clin Invest, 93, pp.2127~2133 (1994)
49. Molina P, "Vitamin D, a modulator of musculoskeletal health in chronic kidney disease", J Cachexia Sarcopenia Muscle, 8, pp.686~701 (2017)
50. Carrero JJ, "Low serum testosterone increases mortality risk among male dialysis patients", J Am Soc Nephrol, 20, pp.613~620 (2009)
51. Hu Z, "Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice", J Clin Invest, 119, pp.3059~3069 (2009)
52. Gungor O, "Effects of hormonal changes on sarcopenia in chronic kidney disease : where are we now and what can we do?", J Cachexia Sarcopenia Muscle, 12, pp.1380~1392 (2021)
53. Gharahdaghi N, "Links between testosterone, oestrogen, and the growth hormone", insulinlike growth factor axis and resistance exercise muscle adaptations, 2021, pp.11, 621226~
54. Hendriks FK, "End-stage renal disease patients lose a substantial amount of amino acids during hemodialysis", J Nutr, 150, pp.1160~1166 (2020)
55. Ikizler TA, "Amino acid and albumin losses during hemodialysis", Kidney Int, 46, pp.830~837 (1994)
56. Popkov VA, "Mitochondria as a source and a target for uremic toxins", Int J Mol Sci, 20, pp.3094~ (2019)
57. Pieniazek A, "Uremic toxins and their relation with oxidative stress induced in patients with CKD", Int J Mol Sci, 22, pp.6196~ (2021)
58. Todoriki S, "Methylglyoxal induces inflammation, metabolic modulation and oxidative stress in myoblast cells", Toxins(Basel), 14, pp.263~ (2022)
59. Edamatsu T, "Phenyl sulfate, indoxyl sulfate and p-cresyl sulfate decrease glutathione level to render cells vulnerable to oxidative stress in renal tubular cells", PloS one, 13, pp.e0193342~ (2018)
60. Bindels LB, "Muscle wasting : the gut microbiota as a new therapeutic target?", Int J Biochem Cell Biol, 45, pp.2186~2190 (2013)
61. Vaziri ND, "Chronic kidney disease alters intestinal microbial flora", Kidney Int, 83, pp.308~315 (2013)
62. Ramezani A, "The gut microbiome, kidney disease, and targeted interventions", J Am Soc Nephrol, 25, pp.657~670 (2014)
63. Wang XH, "MicroRNA in myogenesis and muscle atrophy", Curr Opin Clin Nutr Metab Care, 16, pp.258~ (2013)
64. Pupim LB, "Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients", J Clin Invest, 110, pp.483~492 (2002)
65. Pupim LB, "Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status", J Am Soc Nephrol, 17, pp.3149~3157 (2006)
66. Tomayko EJ, "Intradialytic protein supplementation reduces inflammation and improves physical function in maintenance hemodialysis patients", J Ren Nutr, 25, pp.276~283 (2015)
67. Matsuzawa R, "The effects of amino acid", protein supplementation in patients undergoing hemodialysis : a systematic review and meta-analysis of randomized controlled trials, 2021, pp.44, 114~121
68. Weiner DE, "Oral intradialytic nutritional supplement use and mortality in hemodialysis patients", Am J Kidney Dis, 63, pp.276~285 (2014)
69. Maruyama T, "Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis : a randomized controlled trial", Eur J Clin Nutr, 73, pp.293~301 (2019)
70. Fitschen PJ, "Efficacy of beta-hydroxy-beta-methylbutyrate supplementation in maintenance hemodialysis patients", Hemodial Int, 21, pp.107~116 (2017)
71. Ju SH, "Leucine-enriched amino acid supplementation and exercise to prevent sarcopenia in patients on hemodialysis : a single-arm pilot study", Front Nutr, 10, pp.1069651~ (2023)
72. Shah AP, "Is there a role for ketoacid supplements in the management of CKD?", Am J Kidney Dis, 65, pp.659~673 (2015)
73. Garibotto G, "How to overcome anabolic resistance in dialysis-treated patients?", Front Nutr, 8, pp.701386~ (2021)
74. Baker LA, "Clinical practice guideline exercise and lifestyle in chronic kidney disease", BMC Nephrol, 23, pp.1~36 (2022)
75. Clarkson MJ, "Exercise interventions for improving objective physical function in patients with end-stage kidney disease on dialysis : a systematic review and meta-analysis", Am J Physiol Renal Physiol, 316, pp.F856~F872 (2019)
76. March DS, "The effect of non-pharmacological and pharmacological interventions on measures associated with sarcopenia in end-stage kidney disease : a systematic review and metaanalysis", Nutrients, 14, pp.1817~ (2022)
77. Sheng K, "Intradialytic exercise in hemodialysis patients : a systematic review and meta-analysis", Am J Nephrol, 40, pp.478~490 (2014)
78. Hendriks FK, "Dietary protein and physical activity interventions to support muscle maintenance in end-stage renal disease patients on hemodialysis", Nutrients, 11, pp.2972~ (2019)
79. Young HM, "Effects of intradialytic cycling exercise on exercise capacity, quality of life, physical function and cardiovascular measures in adult haemodialysis patients : a systematic review and meta-analysis", Nephrol Dial Transplant, 33, pp.1436~1445 (2018)
80. Zhao Q, "Non-pharmacological interventions to improve physical function in patients with end-stage renal disease : a network meta-analysis", Am J Nephrol, 54, pp.35~41 (2023)
81. Macdonald JH, "Nandrolone decanoate as anabolic therapy in chronic kidney disease : a randomized phase II dose-finding study", Nephron Clin Pract, 106, pp.c125~c135 (2007)
82. Johansen KL, "Anabolic effects of nandrolone decanoate in patients receiving dialysis : a randomized controlled trial", JAMA, 281, pp.1275~1281 (1999)
83. Supasyndh O, "Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients", Clin J Am Soc Nephrol, 8, pp.271~279 (2013)
84. Becker C, "Myostatin antibody(LY2495655)in older weak fallers : a proof-ofconcept, randomised, phase 2 trial", Lancet Diabetes Endocrinol, 3, pp.948~957 (2015)
85. Hung AM, "IL-1β receptor antagonist reduces inflammation in hemodialysis patients", J Am Soc Nephrol, 22, pp.437~442 (2011)
86. Kittiskulnam P, "Impact of serum bicarbonate levels on muscle mass and kidney function in pre-dialysis chronic kidney disease patients", Am J Nephrol, 51, pp.24~34 (2020)
87. Abramowitz MK, "Effects of oral sodium bicarbonate in patients with CKD", Clin J Am Soc Nephrol, 8, pp.714~720 (2013)
88. Garibotto G, "Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients", J Clin Invest, 99, pp.97~105 (1997)
89. Hansen T, "Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A doubleblind, randomized, placebo-controlled study", Clin Nephrol, 53, pp.99~107 (2000)
90. Pupim LB, "Recombinant human growth hormone improves muscle amino acid uptake and whole-body protein metabolism in chronic hemodialysis patients", Am J Clin Nutr, 82, pp.1235~1243 (2005)
91. Niemczyk S, "A super-agonist of growth hormone-releasing hormone causes rapid improvement of nutritional status in patients with chronic kidney disease", Kidney Int, 77, pp.450~458 (2010)
92. Bajaj M, "Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus", J Clin Endocrinol Metab, 95, pp.1916~1923 (2010)
93. Yokota T, "Pioglitazone improves whole-body aerobic capacity and skeletal muscle energy metabolism in patients with metabolic syndrome", J Diabetes Investig, 8, pp.535~541 (2017)
94. Yen CL, "Pioglitazone reduces mortality and adverse events in patients with type 2 diabetes and with advanced chronic kidney disease : national cohort study", Diabetes Care, 43, pp.e152~ (2020)
95. Bataille S, "The"doseeffect"relationship between 25-hydroxyvitamin D and muscle strength in hemodialysis patients favors a normal threshold of 30 ng", mL for plasma 25-hydroxyvitamin D, 2016, pp.26, 45~52
96. Wang L, "Relation of serum 25-hydroxyvitamin D Status with skeletal muscle mass and grip strength in patients on peritoneal dialysis", J Nutr Sci Vitaminol(Tokyo), 65, pp.477~482 (2019)
97. Gordon PL, "Relationship between vitamin D and muscle size and strength in patients on hemodialysis", J Ren Nutr, 17, pp.397~407 (2007)
98. Taskapan H, "Vitamin D and muscle strength, functional ability and balance in peritoneal dialysis patients with vitamin D deficiency", Clin Nephrol, 76, pp.110~116 (2011)
99. Ashby DR, "Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment", Kidney Int, 76, pp.199~206 (2009)
100. Wynne K, "Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis : a randomized, placebo-controlled trial", J Am Soc Nephrol, 16, pp.2111~2118 (2005)
101. Campbell GA, "Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients : a randomized blinded study", Nephrol Dial Transplant, 33, pp.523~530 (2018)
102. Monfared A, "Effect of megestrol acetate on serum albumin level in malnourished dialysis patients", J Ren Nutr, 19, pp.167~171 (2009)
103. Gołębiewska JE, "Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patients", Int Urol Nephrol, 44, pp.1211~1222 (2012)
104. Valenzuela PL, "Intradialytic neuromuscular electrical stimulation improves functional capacity and muscle strength in people receiving haemodialysis : a systematic review", J Physiother, 66, pp.89~96 (2020)
105. Cho YS, "Effect of extracorporeal shock wave therapy on muscle mass and function in patients undergoing maintenance hemodialysis : a randomized controlled pilot study", Ultrasound Med Biol, 47, pp.3202~3210 (2021)
106. Dompe C, "Photobiomodulation-underlying mechanism and clinical applications", J Clin Med, 9, pp.1724~ (2020)
107. Schardong J, "Photobiomodulation therapy increases functional capacity of patients with chronic kidney failure : randomized controlled trial", Lasers Med Sci, 36, pp.119~129 (2021)
108. Macagnan FE, "Acute effect of photobiomodulation therapy on handgrip strength of chronic kidney disease patients during hemodialysis", Lasers Med Sci, 34, pp.835~840 (2019)
109. Dienemann T, "Changes in body composition, muscle strength, and fat distribution following kidney transplantation", Am J Kidney Dis, 78, pp.816~825 (2021)
110. Kosoku A, "The change in muscle mass among kidney transplant recipients : a prospective cohort study", Transplant Proc, 54, pp.346~350 (2022)
111. Moreau K, "Evolution of body composition following successful kidney transplantation is strongly influenced by physical activity : results of the CORPOS study", BMC Nephrol, 22, pp.31~ (2021)
112. Deger SM, "Insulin resistance is a significant determinant of sarcopenia in advanced kidney disease", Am J Physiol Endocrinol Metab, 315, pp.E1108~E1120 (2018)
113. Dember LM, "A randomized controlled pilot trial of anakinra for hemodialysis inflammation", Kidney Int, 102, pp.1178~1187 (2022)
114. Zanchi A, "Pioglitazone improves fat distribution, the adipokine profile and hepatic insulin sensitivity in non-diabetic end-stage renal disease subjects on maintenance dialysis : a randomized cross-over pilot study", PloS one, 9, pp.e109134~ (2014)
115. Rattanasompattikul M, "Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients(AIONID)study : results of the pilot-feasibility, double-blind, randomized, placebocontrolled trial", J Cachexia Sarcopenia Muscle, 4, pp.247~257 (2013)
116. Hung AM, "Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients", Nephrol Dial Transplant, 30, pp.266~274 (2015)

관련 논문AI추천